CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer
Our study underscores the pivotal role of CDT1 in the progression from NAFLD to HCC. This finding opens new avenues for early diagnosis and targeted therapy of HCC, highlighting CDT1 as a potential therapeutic target.
Authors
- Xiangyu Yang (ORCID: https://orcid.org/0000-0002-4373-7630)
- Jun Ma (ORCID: https://orcid.org/0000-0002-3442-4595)
- Zheng Shi (ORCID: https://orcid.org/0000-0002-1921-1145)
- Lijie Zhang (ORCID: https://orcid.org/0000-0002-9435-9799)
- Na Li (ORCID: https://orcid.org/0000-0002-0392-6672)
- Yan Xue (ORCID: https://orcid.org/0000-0001-6664-3189)
- Xingyu He
- Ping Wang (ORCID: https://orcid.org/0000-0002-9922-5407)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Chengdu University (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- Current Genomics
- Published
- 2024-10-08
- DOI
- https://doi.org/10.2174/0113892029313473240919105819
- Citations
- 20
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.73